US 11052118
Enhanced stem cell composition
granted A61KA61K2035/124A61K35/28
Quick answer
US patent 11052118 (Enhanced stem cell composition) held by Fate Therapeutics, Inc. expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2035/124, A61K35/28, A61K35/51, A61P